Skip to main content

Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan

Abstract

The aim of our study was to assess the association between green tea consumption and all-cause and cause-specific mortality in a pooled analysis of eight Japanese population-based cohort studies. Pooled hazard ratios (HR) and 95% confidence intervals (CI), derived from random effects models, were used to evaluate the associations between green tea consumption, based on self-report at baseline, and risk of all-cause and cause-specific mortality. During a mean follow-up of 17.3 years, among 313,381 persons, 52,943 deaths occurred. Compared with individuals who consumed < 1 cup/day, those in the highest consumption category (≥ 5 cups/day) had a decreased risk of all-cause mortality [the multivariate-adjusted HR was 0.90 (95% CI 0.87–0.94) for men and 0.82 (0.74–0.90) for women]. A similar inverse association was observed for heart disease mortality [HR 0.82 (0.75–0.90) for men, and 0.75 (0.68–0.84) for women], and cerebrovascular disease mortality [HR 0.76 (0.68–0.85) for men, and 0.78 (0.68–0.89) for women]. Among women, green tea consumption was associated with decreased risk of total cancer mortality: 0.89 (0.83–0.96) for the 1–2 cups/day category and 0.91 (0.85–0.98) for the 3–4 cups/day category. Results for respiratory disease mortality were [HR 0.75 (0.61–0.94)] among 3–4 cup daily consumers and [HR 0.66 (0.55–0.79)] for ≥ 5 cups/day. Higher consumption of green tea is associated with lower risk for all-cause mortality in Japanese, especially for heart and cerebrovascular disease. Moderate consumption decreased the risk of total cancer and respiratory disease mortality in women.

This is a preview of subscription content, access via your institution.

Fig. 1

Abbreviations

JPHC-I:

The Japan Public Health Center-based Prospective Study, Cohort I

JPHC-II:

The Japan Public Health Center-based Prospective Study, Cohort II

JACC:

The Japan Collaborative Cohort Study

MIYAGI:

The Miyagi Cohort Study

OHSAKI:

The Ohsaki National Health Insurance Cohort Study

3-pref MIYAGI:

The Three Prefecture Study—Miyagi portion

3-pref AICHI:

The Three Prefecture Study—Aichi portion

3-pref OSAKA:

The Three Prefecture Study—Osaka portion

References

  1. 1.

    Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21(3):334–50.

    CAS  Article  Google Scholar 

  2. 2.

    Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3:CD005004. https://doi.org/10.1002/14651858.CD005004.pub2.

    Article  Google Scholar 

  3. 3.

    Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, Group JS. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 2006;144(8):554–62.

    Article  Google Scholar 

  4. 4.

    Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296(10):1255–65. https://doi.org/10.1001/jama.296.10.1255.

    CAS  Article  Google Scholar 

  5. 5.

    Suzuki E, Yorifuji T, Takao S, et al. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol. 2009;19(10):732–9. https://doi.org/10.1016/j.annepidem.2009.06.003.

    Article  Google Scholar 

  6. 6.

    Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015;114(5):673–83. https://doi.org/10.1017/S0007114515002329.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30(2):103–13. https://doi.org/10.1007/s10654-014-9960-x.

    CAS  Article  Google Scholar 

  8. 8.

    Arab L, Khan F, Lam H. Tea consumption and cardiovascular disease risk. Am J Clin Nutr. 2013;98(6 Suppl):1651S–9S. https://doi.org/10.3945/ajcn.113.059345.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Larsson SC. Coffee, tea, and cocoa and risk of stroke. Stroke. 2014;45(1):309–14. https://doi.org/10.1161/STROKEAHA.113.003131.

    Article  PubMed  Google Scholar 

  10. 10.

    Johnson R, Bryant S, Huntley AL. Green tea and green tea catechin extracts: an overview of the clinical evidence. Maturitas. 2012;73(4):280–7. https://doi.org/10.1016/j.maturitas.2012.08.008.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Eisenstein M. Tea’s value as a cancer therapy is steeped in uncertainty. Nature. 2019;566(7742):S6.

    CAS  Article  Google Scholar 

  12. 12.

    Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst. 1994;86(11):855–8.

    CAS  Article  Google Scholar 

  13. 13.

    Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology. 2001;12(6):695–700.

    CAS  Article  Google Scholar 

  14. 14.

    Ishikawa A, Kuriyama S, Tsubono Y, et al. Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J Epidemiol Jpn Epidemiol Assoc. 2006;16(5):185–92.

    Article  Google Scholar 

  15. 15.

    Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol. 2007;19(2):171–6. https://doi.org/10.1097/MEG.0b013e32800ff77a.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Wang M, Guo C, Li M. A case-control study on the dietary risk factors of upper digestive tract cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 1999;20(2):95–7.

    CAS  PubMed  Google Scholar 

  17. 17.

    Inoue M, Tajima K, Hirose K, et al. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 1998;9(2):209–16.

    CAS  Article  Google Scholar 

  18. 18.

    Mu LN, Zhou XF, Ding BG, et al. A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24(3):192–5.

    PubMed  Google Scholar 

  19. 19.

    Saito E, Inoue M, Sawada N, et al. Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan Public Health Center-based Prospective Study (JPHC Study). Ann Epidemiol. 2015;25(7):512–518e3. https://doi.org/10.1016/j.annepidem.2015.03.007.

    Article  Google Scholar 

  20. 20.

    Sasazuki S, Inoue M, Shimazu T, et al. Evidence-based cancer prevention recommendations for Japanese. Jpn J Clin Oncol. 2018;48(6):576–86. https://doi.org/10.1093/jjco/hyy048.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Tsugane S, Sawada N. The JPHC study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014;44(9):777–82. https://doi.org/10.1093/jjco/hyu096.

    Article  PubMed  Google Scholar 

  22. 22.

    Tamakoshi A, Yoshimura T, Inaba Y, et al. Profile of the JACC study. J Epidemiol Jpn Epidemiol Assoc. 2005;15(Suppl 1):S4–8.

    Article  Google Scholar 

  23. 23.

    Tsuji I, Nishino Y, Tsubono Y, et al. Follow-up and mortality profiles in the Miyagi Cohort Study. J Epidemiol Jpn Epidemiol Assoc. 2004;14(Suppl 1):S2–6.

    Article  Google Scholar 

  24. 24.

    Tsuji I, Takahashi K, Nishino Y, et al. Impact of walking upon medical care expenditure in Japan: the Ohsaki Cohort Study. Int J Epidemiol. 2003;32(5):809–14. https://doi.org/10.1093/ije/dyg189.

    Article  PubMed  Google Scholar 

  25. 25.

    Sado J, Kitamura T, Kitamura Y, et al. Rationale, design, and profile of the Three-Prefecture Cohort in Japan: a 15-year follow-up. J Epidemiol Jpn Epidemiol Assoc. 2017;27(4):193–9. https://doi.org/10.1016/j.je.2016.05.003.

    Article  Google Scholar 

  26. 26.

    Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001;344(9):632–6. https://doi.org/10.1056/NEJM200103013440903.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Tsubono Y, Kobayashi M, Sasaki S, Tsugane S, JPHC. Validity and reproducibility of a self-administered food frequency questionnaire used in the baseline survey of the JPHC Study Cohort I. J Epidemiol Jpn Epidemiol Assoc. 2003;13(1 Suppl):S125–33. https://doi.org/10.2188/jea.13.1sup_125.

    Article  Google Scholar 

  28. 28.

    Inoue M, Kurahashi N, Iwasaki M, et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1746–53. https://doi.org/10.1158/1055-9965.EPI-08-0923.

    Article  PubMed  Google Scholar 

  29. 29.

    Ogawa K, Tsubono Y, Nishino Y, et al. Validation of a food-frequency questionnaire for cohort studies in rural Japan. Public Health Nutr. 2003;6(2):147–57. https://doi.org/10.1079/PHN2002411.

    Article  PubMed  Google Scholar 

  30. 30.

    Kashino I, Akter S, Mizoue T, et al. Coffee drinking and colorectal cancer and its subsites: a pooled analysis of 8 cohort studies in Japan. Int J Cancer. 2018;143(2):307–16. https://doi.org/10.1002/ijc.31320.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    World Health Organization. International statistical classification of diseases and related health problems. 10th Revision. Geneva: WHO; 1992.

    Google Scholar 

  32. 32.

    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    CAS  Article  Google Scholar 

  33. 33.

    Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65(3):230–40. https://doi.org/10.1136/jech.2009.097311.

    Article  Google Scholar 

  34. 34.

    Saito E, Inoue M, Tsugane S, et al. Smoking cessation and subsequent risk of cancer: a pooled analysis of eight population-based cohort studies in Japan. Cancer Epidemiol. 2017;51:98–108. https://doi.org/10.1016/j.canep.2017.10.013.

    Article  PubMed  Google Scholar 

  35. 35.

    Iwasaki M. Commentary: factors associated with non-participation in cohort studies emphasize the need to generalize the results with care. J Epidemiol Jpn Epidemiol Assoc. 2015;25(2):89–90. https://doi.org/10.2188/jea.JE20140269.

    Article  Google Scholar 

  36. 36.

    Iwasaki M, Yamamoto S, Otani T, et al. Generalizability of relative risk estimates from a well-defined population to a general population. Eur J Epidemiol. 2006;21(4):253–62. https://doi.org/10.1007/s10654-006-0004-z.

    Article  PubMed  Google Scholar 

  37. 37.

    Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140(5):1007–13. https://doi.org/10.3945/jn.109.109314.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Tamakoshi A, Lin Y, Kawado M, et al. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol. 2011;26(4):285–93. https://doi.org/10.1007/s10654-011-9548-7.

    Article  PubMed  Google Scholar 

  39. 39.

    Cui R, Iso H, Eshak ES, Maruyama K, Tamakoshi A, Group JS. Water intake from foods and beverages and risk of mortality from CVD: the Japan Collaborative Cohort (JACC) Study. Public Health Nutr. 2018;21(16):3011–7. https://doi.org/10.1017/S1368980018001386.

    Article  PubMed  Google Scholar 

  40. 40.

    Tani Y, Asakura K, Sasaki S, et al. The influence of season and air temperature on water intake by food groups in a sample of free-living Japanese adults. Eur J Clin Nutr. 2015;69(8):907–13. https://doi.org/10.1038/ejcn.2014.290.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Zhao LG, Li HL, Sun JW, et al. Green tea consumption and cause-specific mortality: results from two prospective cohort studies in China. J Epidemiol Jpn Epidemiol Assoc. 2017;27(1):36–41. https://doi.org/10.1016/j.je.2016.08.004.

    Article  Google Scholar 

  42. 42.

    Liu J, Liu S, Zhou H, et al. Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men. Eur J Epidemiol. 2016;31(9):853–65. https://doi.org/10.1007/s10654-016-0173-3.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Wang H, Provan G, Helliwell K. The functional benefits of flavonoids: the case of tea. In: Johnson I, Williamson G, editors. Phytochemical funtional foods. Cambridge: Woodhead Publishing; 2003.

    Google Scholar 

  44. 44.

    Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician. 2009;79(7):591–4.

    PubMed  Google Scholar 

  45. 45.

    Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007;15(6):1473–83. https://doi.org/10.1038/oby.2007.176.

    CAS  Article  Google Scholar 

  46. 46.

    Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr. 2011;94(2):601–10. https://doi.org/10.3945/ajcn.110.010926.

    CAS  Article  Google Scholar 

  47. 47.

    Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH. Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013;97(4):750–62. https://doi.org/10.3945/ajcn.111.032573.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Zucchi R, Ronca-Testoni S. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev. 1997;49(1):1–51.

    CAS  PubMed  Google Scholar 

  49. 49.

    Spyridopoulos I, Fichtlscherer S, Popp R, et al. Caffeine enhances endothelial repair by an AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol. 2008;28(11):1967–74. https://doi.org/10.1161/ATVBAHA.108.174060.

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Welsh EJ, Bara A, Barley E, Cates CJ. Caffeine for asthma. Cochrane Database Syst Rev. 2010;1:CD001112. https://doi.org/10.1002/14651858.CD001112.pub2.

    Article  Google Scholar 

  51. 51.

    Yang CS, Lee MJ, Chen L, Yang GY. Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect. 1997;105(Suppl 4):971–6.

    CAS  Article  Google Scholar 

  52. 52.

    Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009;9(6):429–39. https://doi.org/10.1038/nrc2641.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Japanese Cancer Prevention Group. Green tea and stomach cancer risk [in Japanese]. National Cancer Center. https://epi.ncc.go.jp/can_prev/evaluation/2947.html. Accessed 12 Nov 2018.

  54. 54.

    Inoue M, Sasazuki S, Wakai K, et al. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut. 2009;58(10):1323–32. https://doi.org/10.1136/gut.2008.166710.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Suzuki Y, Tsubono Y, Nakaya N, Suzuki Y, Koizumi Y, Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer. 2004;90(7):1361–3. https://doi.org/10.1038/sj.bjc.6601652.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis. 2008;29(10):1967–72. https://doi.org/10.1093/carcin/bgn177.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  57. 57.

    Lin Y, Kikuchi S, Tamakoshi A, et al. Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas. 2008;37(1):25–30. https://doi.org/10.1097/MPA.0b013e318160a5e2.

    CAS  Article  PubMed  Google Scholar 

  58. 58.

    Islami F, Poustchi H, Pourshams A, et al. A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma. Int J Cancer. 2019. https://doi.org/10.1002/ijc.32220.

    Article  PubMed  Google Scholar 

  59. 59.

    Dietz C, Dekker M. Effect of green tea phytochemicals on mood and cognition. Curr Pharm Des. 2017;23(19):2876–905. https://doi.org/10.2174/1381612823666170105151800.

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    Wang Y, Ho CT. Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem. 2009;57(18):8109–14. https://doi.org/10.1021/jf804025c.

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the National Cancer Center Research and Development Funds (30-A-15, 27-A-4, 24-A-3) and the Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer (H21-3jigan-ippan-003, H18-3jigan-ippan-001, H16-3jigan-010). The funders had no role in the design, data collection, analysis, interpretation or manuscript drafting, or in the decision to submit the manuscript for publication.

Author information

Affiliations

Authors

Consortia

Contributions

MI designed the research. SKA performed the analyses, prepared the tables and drafted the paper. MI, ES, NS, ST, YL, and AS supported analyses, discussions and finalizing of the paper. HI, YL, AT, JS, YK, YS, IT, CN, TS, TM, KM, MN, and KT provided valuable feedback regarding interpretation of the results. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Manami Inoue.

Ethics declarations

Conflict of interest

The authors have no potential conflicts of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

For the Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan: Research group members are listed at the following site (as of August 2018): http://epi.ncc.go.jp/en/can_prev/796/7955.html.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abe, S.K., Saito, E., Sawada, N. et al. Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan. Eur J Epidemiol 34, 917–926 (2019). https://doi.org/10.1007/s10654-019-00545-y

Download citation

Keywords

  • Green tea
  • Mortality
  • Cohort study
  • Pooled analysis
  • Japan